Labshake search
Citations for Tocris :
1 - 50 of 294 citations for TGF beta 4 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2020Quote: ... and TGF-beta inhibitor A83-01 (100nM, Tocris). The tissue was then agitated for one hour at 37C and the resultant cell suspension was filtered through 100 through 40 μm cell strainers and subjected to ammonium chloride red blood cell lysis ...
-
bioRxiv - Developmental Biology 2021Quote: ... the TGF-beta/Activin/Nodal inhibitor SB-431542 (2 μM, Tocris), CHIR99021 (1 μM) ...
-
bioRxiv - Cancer Biology 2022Quote: ... the TGF-beta/Activin/Nodal inhibitor SB-431542 (2 μM, Tocris), CHIR99021 (1 μM ...
-
bioRxiv - Bioengineering 2023Quote: ... and TGF-Beta inhibitor (SB431542, Tocris # 1614, 5 μM, days 0-7). Media was changed on days 3 and 6 and then every 2-3 days until day 7 ...
-
bioRxiv - Cancer Biology 2022Quote: ... the TGF-beta/Activin/Nodal inhibitor SB-431542 (2 μM, Cat# 1614, Tocris), CHIR99021 (1 μM ...
-
bioRxiv - Microbiology 2021Quote: ... TGF-ß inhibitor (0.5 mM; Tocris), Rock inhibitor (10 mM ...
-
bioRxiv - Immunology 2023Quote: ... TGF-β inhibitor A83-01 (500nM, Tocris), p38 inhibitor SB202190 (10µM ...
-
bioRxiv - Immunology 2024Quote: ... TGF-β inhibitor A83-01 (500 nM, Tocris), p38 inhibitor SB202190 (10 µM ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 μM TGF-β inhibitor SB431542 (Tocris, Cat. 1614), and 10 μM of prednisolone (Sigma-Aldrich ...
-
bioRxiv - Cancer Biology 2020Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 0.5µM TGF-b inhibitor A-83-01 (TOCRIS 2939), 0.05µg/mL EGF (Thermo Fisher PMG8041) ...
-
bioRxiv - Developmental Biology 2019Quote: ... and 10µM SB431542 (TGF-β signalling inhibitor; Tocris Bioscience). For mesoderm differentiation cells were plated on gelatin and mouse embryonic fibroblast (MEF ...
-
bioRxiv - Cancer Biology 2022Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
Interactions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumorsbioRxiv - Cancer Biology 2020Quote: ... 0.5 μM TGF-b inhibitor A-83-01 (TOCRIS 2939), 0.05 μg/mL EGF (Thermo Fisher PMG8041) ...
-
bioRxiv - Cell Biology 2022Quote: ... TGF-β inhibitor A 83-01 (5 uM, Tocris bioscience), VEGF-121 (10 ng/mL ...
-
bioRxiv - Bioengineering 2019Quote: ... TGF-β type I receptor inhibitor A83-01 500nM (Tocris), P38 inhibitor SB202190 10μM(Sigma-Aldrich) ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (5ng/ml; carrier-free; Tocris R&D Systems), anti-IFNγ antibody (2 ug/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... TGF-β inhibitor A 83-01 (5 uM, Tocris bioscience), Fungin (10μg/ml ...
-
bioRxiv - Bioengineering 2021Quote: ... and TGF-βinhibitor (SB431542, Tocris, 1614, 5 µM, days 0-10). On Day 2 ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (30 ng/ml; carrier-free; Tocris R&D Systems), IL-6 (30 ng/ml ...
-
bioRxiv - Cancer Biology 2023Quote: ... 500 nM TGF-b type I receptor inhibitor A83-01 (Tocris), 10 µM P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Biochemistry 2023Quote: ... 500 nM A83-01 TGF-ß type 1 receptor inhibitor (Tocris) and 10 µM SB202190 P38 MAPK inhibitor (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 0.5 μM TGF-b type I receptor inhibitor A83-01 (Tocris Bioscience) and 1μM PGE2 (Tocris Bioscience) ...
-
bioRxiv - Cell Biology 2020Quote: ... TGF-βR1 inhibitor (SB431542) and JAK2 inhibitor (AG490) were purchased from Tocris Bioscience (1614-10MG) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 5000 nM TGF-b type I receptor inhibitor A83-01 (Tocris #2939), 10 nM Prostaglandin E2 (Tocris #2296) ...
-
bioRxiv - Neuroscience 2023Quote: ... SB431542 (TGF-β/SMAD inhibitor; 1614) and ROCK inhibitor (1254) was from Tocris. LDN193189 (BMP inhibitor ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 µM Dihydro-beta-erythroidine hydrobromide (DHBE, Tocris), which is selective for alpha4-containing nicotinic receptors ...
-
bioRxiv - Cancer Biology 2024Quote: ... Murine CGRP peptide (Tocris) was dissolved in PBS and given at a concentration of 1 μM in vitro ...
-
bioRxiv - Neuroscience 2021Quote: ... Alexa-fluorophore conjugated secondary antibodies were added in blocking solution for 1 hour at 4°C followed by treatment with Methoxy-X04 (Tocris, 4920) for 15 minutes at room temperature to label amyloid-beta plaques ...
-
bioRxiv - Developmental Biology 2021Quote: ... For inhibition of the TGF-β pathway we used A-83-01 (Tocris, cat. no. 2939). Media was changed daily ...
-
bioRxiv - Neuroscience 2022Quote: The following peptides and drugs were used: myristoylated dynamin inhibitory peptide (50 µM; Tocris Bioscience), TTX (1 µM ...
-
bioRxiv - Cancer Biology 2021Quote: ... 230 μM RGDS peptide (Tocris, #3498) in PBS ...
-
bioRxiv - Immunology 2023Quote: ... the human Aβ42 peptide (Tocris Bioscience) was dissolved at a concentration of 100 nM in 50 μ𝓁 of 0.1 M sodium bicarbonate coating buffer (pH 8.6) ...
-
bioRxiv - Cell Biology 2023Quote: ... or PAR4 peptide (PAR4; #3494, Tocris)) and the respective antibodies for 15 min at 37 °C in the dark ...
-
bioRxiv - Molecular Biology 2023Quote: ... RGDS peptide (Tocris, 3498, 10 μg/ml), NSC23766 (Tocris ...
-
bioRxiv - Cell Biology 2019Quote: Human PSC were grown for 5 days in E8 media(Chen et al., 2011) without FGF-2 and TGF-b but supplemented with 10μM CHIR99021 (Tocris, 4423). Loss of pluripotency was confirmed by RT-qPCR panel of self-renewal ...
-
bioRxiv - Neuroscience 2020Quote: ... Pluripotent hESCs were incubated with small molecules to start the dual SMAD inhibition: BMP and TGF-b receptors were pharmacologically blocked with 100 nM LDN193189 (Stemgent) and 10 mM SB431542 (Tocris), respectively ...
-
bioRxiv - Cell Biology 2019Quote: ... and scramble control peptide were purchased from Tocris Biosciences (Minneapolis ...
-
bioRxiv - Neuroscience 2020Quote: ... gastrin-releasing peptide (GRP, 286 ng, Tocris, 1789), NK1R antagonist CP 99994 (18 μg ...
-
bioRxiv - Molecular Biology 2021Quote: Spexin peptide (Cat. #6090) was purchased from Tocris Bioscience (Bio-Techne Corporation ...
-
bioRxiv - Cell Biology 2023Quote: ... a membrane permeable PKA inhibitor peptide (Tocris Bioscience) at 1uM for 6 hours ...
-
bioRxiv - Immunology 2024Quote: ... Ac2-26 peptide (AMVSEFLKQAWFIENEEQEYVQTVK) was purchased from Tocris Biosciences ...
-
bioRxiv - Cell Biology 2024Quote: ... 1.0×105 cells/cm2 for anti-fibrotic condition consisting in FibroGRO 2% FBS supplemented with 75ng/mL of bFGF and 500nM of TGF-β inhibitor (A83-01, Tocris). iPSC-cFbs were maintained for 7 days in culture replacing medium each second day ...
-
bioRxiv - Cancer Biology 2022Quote: The following chemical inhibitors targeting different effectors of the TGF-β-pathway were used: TGFbR-inhibitor A83-01 [50 nM] (Tocris Bioscience), p38-inhibitors SB202190 [10 μM] (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2020Quote: ... Blocking GABAA receptors with SR 95531 hydrobromide (100 μM) (Tocris) led to over-excitability of the PN dendrites and irregular spontaneous spiking behavior ...
-
bioRxiv - Developmental Biology 2022Quote: 4-Hydroxytamoxifen (4-OHT) (Tocris Bioscience) was dissolved in corn oil (Millipore-Sigma ...
-
bioRxiv - Neuroscience 2020Quote: ... cells were pre-blocked using EphA4 antagonist peptide (KYL; Tocris) or EphA2 monoclonal antibody (Abcam ...
-
bioRxiv - Neuroscience 2020Quote: Chemicals blockers or peptide inhibitors (all from Tocris Bioscience, NM) applied directly in the media were used to block ion channels or manipulate cellular pathways ...
-
bioRxiv - Cell Biology 2023Quote: ... Embryos were injected with 1 mM RGDS peptide (Tocris Bioscience) in water ...
-
bioRxiv - Neuroscience 2020Quote: ... 4-aminopyrimidine (4-ap, 30 µM, Tocris) and/or Tetrodotoxin (TTX ...